A post‑meal compound found in python blood curbed appetite in lab mice, hinting at future weight loss therapies.

Scientists discovered GLP-1 mimics like Ozempic by way of the Gila monster, and now, a metabolite in python blood is also ...

March 19 (Reuters) - OpenAI said on Thursday it will acquire Python toolmaker Astral, as the ChatGPT ​owner looks to ...

OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

Python’s Kiss” is a highly anticipated collection of 13 stories by Louise Erdrich, illustrated with artwork by Erdrich’s ...

Thinking of a pet snake? Skip the dander and daily walks. We explore the costs, lifespan, and best beginner species for ...

This snake in an Australian suburb was carrying an astonishing number of parasitic hitchhikers.

OpenAI has acquired Astral, a startup whose essential Python development tools are used by millions. This strategic move aims ...

New research suggests python blood could hold the key to a new weight-loss drug, as the snake metabolite suppresses appetites in mice. It is the ...

Researchers have identified fossil evidence of a giant python — estimated to exceed 13 feet in length — that once lived on ...

OpenAI has agreed to acquire Astral, a startup behind widely used Python development tools, in a deal designed to sharpen its Codex coding assistant as competition with Anthropic intensifies. The ...

Researchers have found a metabolite in Burmese pythons that suppresses appetite in mice without some of GLP-1's side effects. And humans make it, too.